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Structural propertiesTo gain insight into the structural and functional properties of the vesicular stomatitis virus nucleocapsid–
RNA complex (vN–RNA), we analyzed it by treatment with proteolytic enzymes. Chymotrypsin treatment to
the vN–RNA results in complete digestion of the C-terminal 86 amino acids of the N protein. The residual
chymotrypsin resistant vN–RNA complex (vΔN–RNA) carrying N-terminal 336 amino acids of the N protein
(ΔN) was inactive in transcription. The ΔN protein retained its capability to protect the genomic RNA from
nuclease digestion but failed to interact to the P protein. Interestingly, addition of excess amount of P protein
rendered the vN–RNA complex resistant to the chymotrypsin digestion. Finally, our data revealed that the
recombinant N–RNA complex puriﬁed from bacteria (bN–RNA) is resistant to chymotrypsin digestion,
suggesting that the C-terminal unstructured domain (C-loop) remains inaccessible to protease digestion.
Detailed comparative analyses of the vN–RNA and vΔN–RNA are discussed.Genetics, Section of Virology,
Avenue, Cleveland, OH 44195,
physics, Case Western Reserve
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Vesicular stomatitis virus (VSV), a prototype of non-segmented
negative stranded RNA virus belonging to the rhabdovirus family,
contains a single stranded RNA genome of negative polarity consisting
of 11,161 nucleotides (Banerjee, 1987; Banerjee et al., 1991; Banerjee
and Barik, 1992; Rose and Schubert, 1987). The viral genomic RNA
is encapsidated by ∼1200 molecules of nucleocapsid (N) protein
(47 kDa) to form the nuclease resistant viral N–RNA complex (vN–
RNA), which serves as the template for mRNA transcription as well as
genome replication (Banerjee, 1987; Thomas et al., 1985). The vN–
RNA complex associates with ∼50 copies of L protein (242 kDa), the
RNA-dependent RNA polymerase (RdRp) and ∼500 copies of the P
protein (30 kDa), a cofactor for the L protein, to form the transcribing
viral ribonucleoprotein complex (vRNP) (Emerson and Yu, 1975;
Thomas et al., 1985; De and Banerjee, 1985). The P protein, which
interacts with both N and L proteins, mediates the contact between
the vN–RNA template and the L protein (Mellon and Emerson, 1978).
However, the interesting question as to how the RdRp gains access to
the promoter for the initiation of transcription and carries out subse-
quent RNA chain elongation, while the N-protein molecules remainassociated with the genome RNA, still remains an enigma. Due to high
molecular weight and structural complexity, the crystal structure of
the vRNP or the vN–RNA complexes remained unsolved to date.
Similarly, effective packaging of the full-length genome RNA in vitro
using recombinant N protein has also been unsuccessful. Only a short
leader RNA (47 bases) was encapsidated in vitro with the N protein,
albeit inefﬁciently although it remained protected against ribonucle-
ase digestion (Das and Banerjee, 1992; Das et al., 1999).
Recently, Green et al. (2000, 2006) have been able to purify
recombinant N–RNA complex from Escherichia coli and solved the
crystal structure at 2.9 Å. This N–RNA complex (bN–RNA) consists of
10 molecules of recombinant VSV N protein and 90 nucleotides of
bacterial RNA. Each N molecule in the ring-like bN–RNA oligomer has
a bilobed structure with the RNA tightly bound in the cavity at the
interface between the N- and C-terminal helical lobes (Green et al.,
2006). Importantly, the VSV N proteinwas able to protect the bacterial
RNA from ribonuclease action presumably by tight contacts with
several key amino acid residues of the N protein residing in themiddle
of the protein (Green et al., 2006). Concurrently, elucidation of crystal
structure of the rabies virus recombinant N–RNA complex, puriﬁed
from the insect cells also showed similar ring-like and bilobed
structure (Albertini et al., 2006). Recently, electron micrographic
analyses of the respiratory syncytial virus (RSV) and Mumps virus
(Mu V) recombinant N–RNA complexes, puriﬁed from insect cells
and E. coli, respectively, also revealed similar ring-like morphology
(MacLellan et al., 2007; Cox et al., 2009). However, since the
recombinant bN–RNA complexes lacked the viral genomic RNA it
was not possible to test if they can serve as template for the viral RdRp
holoenzyme complexes in a transcription/reconstitution system.
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impetus to probe into its structure using biochemical techniques
particularly by treatment with several proteases. Here, we demon-
strate that chymotrypsin treatment of the vN–RNA complex removes
precisely 86 amino acids from the C-terminal end of the N protein.
Detailed comparative biochemical analyses of the vN–RNA and the
chymotrypsin-treated vΔN–RNA provided a deeper insight into the
structure of the vN–RNA complex.Results
Protease digestion of the virion N–RNA complex
The virion N–RNA complex (vN–RNA), puriﬁed from mature VSV
particles through CsCl equilibrium density gradient centrifugation
was resolved in SDS-PAGE and detected by Coomassie brilliant blue
(CBB) staining and Western blot analysis using anti-N antibody.
As shown in Fig. 1A a single band of the N protein was discernible
conﬁrming the purity of the vN–RNA preparation. This puriﬁed vN–
RNA was used in all of the subsequent experiments. To probe into the
spatial arrangement of the N protein bound to the genome RNA, we
initiated studies by treatment of vN–RNA complex with several
proteases, such as trypsin, pepsin and chymotrypsin. As shown in
Fig. 1B, we conﬁrmed our earlier studies that controlled proteolysis
by chymotrypsin digested a portion of N-protein (∼10 kDa) from
vN–RNA complex leaving a ∼37 kDa N-protein intact (Banerjee et al.,
1987). Treatment with trypsin or pepsin failed to digest the N protein
from the vN–RNA complex (data not shown). To obtain quantitative
estimation of the extent of proteolysis, vN–RNA was incubated with
chymotrypsin with different (w/w) ratios (vN–RNA:chymotrypsin=
4.25:1 or 8.5:1 or 17:1) in a buffer containing 10 mM Tris–HCl, pH 8.0
at 37 °C for 20 min. As shown in Fig. 1B, chymotrypsin treatment, at a
ratio of 17:1 or 8.5:1 (lanes 4 and 5) resulted in the production of
∼37 kDa N-protein (ΔN protein), although some residual, uncleaved
N protein was also observed. At higher concentration of the chymo-
trypsin (vN–RNA:chymotrypsin=4.25:1), the N protein was com-Fig. 1. Chymotrypsin digestion of virion N–RNA. (A) Puriﬁed vN–RNA complex was mixed w
was visualized by either CBB stain (lane 2) or WB with anti-VSV N polyclonal antibody (la
proﬁle of vN–RNA complex at three different (w:w) ratios. (C) Time kinetics proﬁle of chym
from 0–20 min.pletely digested to produce the ΔN protein only (Fig. 1B, lane 6).
As shown in Fig. 1C, the chymotrypsin digestion for 5 min at 37 °C
resulted in virtually 100% conversion of N to ΔN and the ΔN remains
intact till 20 min of incubation. Thus it seems that chymotrypsin
treatment speciﬁcally cleaves and digests a portion of the N protein
from the complex (∼10 kDa). In subsequent experiments we main-
tained the abovementioned concentration of chymotrypsin (vN–RNA:
chymotrypsin=4.25:1) and incubation time (20 min).
Mass spectrometric analysis of the ΔN protein
To determine the exact chymotrypsin cleavage site, the full-length
N (47 kDa) and the ΔN (∼37 kDa) proteins were subjected to mass
spectrometric analysis as described in Materials and methods. A
comparative analysis of the protein sequences identiﬁed in the N and
the ΔN bands showed that the chymotryptic truncation occurred at
the C-terminal portion of the N protein (Fig. 2) at a tyrosine (Y336)
residue (shown in larger font). These results clearly indicate that
the C-terminal 86 amino acids (designated as NC-86) of calculated
molecular mass 9.5 kDa was speciﬁcally digested by chymotrypsin
(shown in italics), indicating that only this domain of the N protein in
the vN–RNA complex remains accessible to the chymotrypsin action.
The chymotrypsin cleavage site in the N protein is shown in Fig. 2B.
Biochemical analyses of the vΔN–RNA
To address the structural and functional alterations that occurred to
the vN–RNA complex following chymotrypsin digestion, we studied
the following biochemical properties of the vΔN–RNA complex.
(a) Structural integrity of the vΔN–RNA
The puriﬁed vN–RNA template was digested with chymotrypsin
(vN–RNA:chymotrypsin=4.25:1) for 20 min and banded in CsCl
equilibrium density gradient ultracentrifugation as described in
Materials and methods. As a control, puriﬁed vN–RNA was similarly
banded in CsCl and collected fractions were analyzed by 15% SDS-ith SDS-PAGE loading buffer, heated to 100 °C and resolved in SDS-PAGE. The N protein
ne 3). Puriﬁed VSV was used as positive control (lane 1). (B) Chymotrypsin digestion
otrypsin digestion of vN–RNA complex at 4.25:1 (w:w) (vN–RNA:chymotrypsin) ratio
Fig. 2. (A) Amino acid sequence of the VSV N protein. The ΔN portion of the protein, as determined by LC-MS analysis, is shown in regular font and the NC-86 protein (the C-terminal
86 amino acid) is shown in italics. The chymotrypsin cleavage site Y336 is shown in larger font. (B) The structure of the C-terminal nucleocapsid binding domain of the
phosphoprotein (P), PCTD, in complex with two nucleocapsid protein (N) subunits is presented as a ribbon drawing. PCTD (yellow) corresponds to residues 193–265. The two N
subunits (red and green) are oriented so that the cavity that encapsidates RNA is facing away. The chymotrypsin cleavage site in each subunit is marked by an arrow. The cleavage
will remove the C-terminal portion of the N subunits (dark red and dark green) that makes contact with PCTD. The coordinates used for preparing this ﬁgure are derived from PDB
3HHZ. The ﬁgure was prepared with program PyMOL (DeLano, 2002).
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same fractions with similar density in the gradient as the vΔN –RNA
(lanes 4 and 5) suggesting that the overall structural integrity of both
complexes were similar.
(b) Transcription activity of vΔN–RNA
In vitro transcription–reconstitution reaction was performed with
the vL–P complex using vN–RNA or vΔN–RNA complexes as templates
as described in Materials and methods. As shown in Fig. 3B, the vN–
RNA supported in vitro transcription efﬁciently and synthesized full-
lengthmRNAs (lane 3), whereas vΔN–RNAwas completely inactive in
transcription (lane 5). These results conﬁrmed our previous ﬁndings
(Banerjee et al., 1987) and indicated that removal of NC-86 portion
of the N protein rendered the vN–RNA template non-functional in
transcription.
(c) Nuclease sensitivity of the genome RNA in vΔN–RNA
Next, we wanted to test if the truncated nucleoprotein complex
retains its ability to protect the genome RNA from nuclease digestion.
The genome RNA was labeled with 32P-orthophosphate and the vN–
RNA and vΔN–RNA complexes containing 32P-labeled genome RNA
were puriﬁed asdescribed in theMaterials andmethods. The complexes
were incubated with 0, 0.06 and 0.12 (U/μg vN–RNA) of micrococcal
nuclease in separate reaction mixtures containing 50 mM Tris–HCl,pH 8.0, and 4 mM CaCl2 at 30 °C for 1 h. The reactions were terminated
with 10 mM EGTA and SDS was added to a ﬁnal concentration of 0.5%.
The 32P-labeled genomic RNA was resolved in 5% PAGE containing 7 M
urea and detected by autoradiography. As shown in Fig. 3C, the genome
RNA from both the vN–RNA (lanes 2 and 3) and the vΔN–RNA (lanes 5
and 6) complexes were resistant to micrococcal nuclease digestion
indicating that the vΔN–RNA retained the ability to protect the genome
RNA from nuclease action and the NC-86 does not play a direct role in
protecting the genome RNA from digestion by nuclease.
Interaction of vN–RNA and vΔN–RNA with the P protein
Since vΔN–RNAwas found to be inactive in transcription, although
retaining its ability to protect the genomic RNA from nuclease action,
wewanted to test if the lack of template functionwas primarily due to
its inability to interact with the P protein. To test this contention, the
interaction of P protein with the vN–RNA and vΔN–RNA was carried
out in vitro in the followingmanner. A plasmid expressing Myc tagged
P protein (Myc-P) was transfected in HeLa cells and at 20 h post-
transfection cell lysates were prepared and incubated with puriﬁed
vN–RNA or vΔN–RNA for 1 h at 30 °C as detailed in Materials and
methods. The reaction mixtures were diluted and centrifuged at
120,000×g for 1 h and the pelleted protein complexes were analyzed
by Western blot using anti-N and anti-Myc antibodies. As shown in
Fig. 3. Biochemical analyses of vN–RNA and vΔN–RNA. (A) vN–RNA was digested with chymotrypsin to obtain vΔN–RNA and vΔN–RNA was further subjected to CsCl equilibrium
density gradient ultracentrifugation. Puriﬁed proteins were resolved in SDS-PAGE and visualized by CBB stain. Banding proﬁle of vN–RNA (lanes 2 and 3) and vΔN–RNA (lanes 4
and 5) in CsCl equilibrium density gradient centrifugation is shown in ﬁgure. (B) In vitro transcription–reconstitution reaction performed with vL–P and vN–RNA or vΔN–RNA
complexes. 32P-labeled mRNA transcripts were analyzed in 5% urea-PAGE followed by autoradiography. All of the detected transcripts are indicated. (C) 32P-labeled VSV was
prepared and vN–RNA was puriﬁed from the 32P-labeled VSV. The vN–RNA, containing 32P-labeled genome RNA, was digested with chymotrypsin and the digested products were
further puriﬁed through CsCl equilibrium density gradient ultracentrifugation to obtain vΔN–RNA. vN–RNA and vΔN–RNA, containing 32P-labeled genome RNA, were digested with
micrococcal nuclease and resolved in 5% urea-PAGE. The 32P-labeled genomic RNA present within vN–RNA and vΔN–RNA were detected by autoradiography.
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panel) proteins were detected in the pellet. As expected, the vN–RNA
complexwas able to pellet Myc-P (lane 3, upper panel) whereas vΔN–
RNA failed to do so (lane 5, upper panel). The Myc-P when incubated
alone in a control experiment and centrifuged in the same manner
did not pellet (lane 6, upper panel). These data indicate that vΔN–
RNA lost its ability to interact with P protein due to the removal of
C-terminal 86 amino acids.Fig. 4. In vitro interaction between the P protein and vN–RNA or vΔN–RNA. HeLa cells
were transfected with a mock plasmid or a plasmid expressing Myc-P as detailed in
Materials and methods. At 20 h post-transfection lysates were incubated with the vN–
RNA or the vΔN–RNA complexes at 30 °C for 1 h. The reaction mixtures were then
centrifuged at 120,000×g for 1 h using a Sorvall TH-660 rotor. Protein complexes
present in the pellet were detected by Western blot analysis using anti-N or anti-Myc
polyclonal antibodies.We, next, wanted to test if binding to the P protein leads to any
conformational alteration of the vN–RNA complex which is active for
transcription. To test this contention, the vN–RNA was incubated at
30 °C for 1 h with P protein at different molar ratios and the com-
plexes were subjected to chymotrypsin treatment at 4.25:1 (w/w)
(vN–RNA:chymotrypsin) ratio at 37 °C for 20 min. The digested pro-
teins were then resolved in 10% SDS-PAGE and detected by CBB stain.
As expected, vN–RNA was digested by the chymotrypsin to form the
ΔN (Fig. 5A, lane 3) in the absence of P protein prior to digestion.
However, when the P protein was added in increasing amounts fol-
lowed by chymotrypsin treatment, a gradual decrease in the appear-
ance of ΔN was observed (lanes 4–13). Only 80% and 30% ΔN were
produced compared to control at the molar ratios of vN–RNA:P 5:1
and 5:2.5, respectively (Fig. 5A, lanes 5 and 7). At vN–RNA:P molar
ratios 5:5, 5:7.5 and 5:10, vN–RNA became totally resistant to the
chymotrypsin digestion (Fig. 5A, lanes 9, 11 and 13). It is important to
note that at all levels of added P protein, it was completely digested
by the chymotrypsin (lanes 5, 7, 9, 11 and 13) and the N protein
remained intact. Since, the P protein interacts with the vN–RNA
complex through a small region (residues 251–265 of P; helix 4)
(Green and Luo, 2009 and Fig. 2B), it is possible that this region (which
is not detectable in SDS-PAGE after chymotrypsin digestion) is
sufﬁcient to protect the vN–RNA from chymotrypsin digestion.
Alternatively, the P protein, upon binding to the C-terminal domain
of the N protein is capable of altering its conformation to a highly
compact form rendering the protein inaccessible to the chymotrypsin
action. In a control experimentwhen the bacterially expressedpuriﬁed
P protein of mumps virus was used instead of the VSV P protein the
vN–RNA was effectively converted to ΔN following digestion with
Fig. 5. Protease protection assay of vN–RNA complex. (A) vN–RNA complex was incubated with the P protein at 30 °C for 1 h complex formation. Chymotrypsin digestion proﬁle of N
protein within the vN–RNA complex when complexed with P protein formed at different molar ratios (vN–RNA:P=5:0, 5:1; 5:2.5, 5:5, 5:7.5 and 5:10). (B) vN–RNA complex and
puriﬁed P protein of mumps virus (MuV) incubated at 1:1 molar ratio at 30 °C temperature for 1 h and then digested with chymotrypsin as described in Materials and methods.
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protein plays a critical role by speciﬁcally interactingwith the vN–RNA
and protects the vN–RNA from the chymotrypsin action.
Structural properties of N–RNA complex puriﬁed from the infected cells
Since in vitro interaction of the P protein and the vN–RNA complex
protected the latter from chymotrypsin digestion, it was of interest to
test if the RNP complex puriﬁed from VSV infected BHK cells (iRNP)
and its corresponding N–RNA (iN–RNA) prepared from it can be
digested with chymotrypsin. The vRNP and iRNP complexes were
puriﬁed as described in the Materials and methods and subjected
to chymotrypsin treatment at a ratio of 4.25:1 (w/w) (vRNP/iRNP:
chymotrypsin) in the buffer containing 10 mM Tris–HCl, pH 8.0 at
37 °C for 20 min. As shown in Fig. 6A, as expected, the chymotrypsinFig. 6. Chymotrypsin digestion of virion RNP (vRNP), infected cell RNP (iRNP) and infected ce
proﬁle of vRNP and infected cell RNP (iRNP). (B) Chymotrypsin digestion proﬁle of the purtreatment of vRNP resulted in the formation of 37 kDa ΔN product;
the L and P proteins, present in vRNP, were totally digested by the
chymotrypsin (lane 4). In contrast, the puriﬁed iRNP, when treated
similarly with chymotrypsin, no 37 kDa ΔN product was produced
and the N protein remained resistant to the chymotrypsin digestion
(lane 6). As expected, the L and P proteins present in the iRNP were
completely digested by the chymotrypsin (lane 6). Thus, it seems that
similar to the P protein interaction with vN–RNA described above, the
association of excess P proteins to the N protein present in the iRNP
(Hsu et al, 1979; Patton et al., 1983), protected the N protein from
the chymotrypsin digestion. The vRNP, on the other hand, probably
due to the presence of low quantities of P proteins is digestible by
chymotrypsin.
Next, the vN–RNA and iN–RNA (Fig. 6B, lanes 2 and 4) complexes
puriﬁed from the correspondingRNPswere subjected to chymotrypsinll N–RNA (iN–RNA) complexes. (A) Comparative analysis of the chymotrypsin digestion
iﬁed vN–RNA and infected cell N–RNA (iN–RNA), obtained from iRNP.
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shown in Fig. 6B, lane 5, the iN–RNA complex, upon chymotrypsin
treatment, produced the sameΔN fragment suggesting that removal of
the L and P proteins produced a complex which is similar to vN–RNA
complex, again indicating that excess of intracellular L and P proteins
bound to iRNP rendered the structure different from vRNP.
Structural properties of the N–RNA complex puriﬁed from E. coli
Finally, we wanted to study the structure of the N–RNA obtained
from E. coli (bN–RNA), the crystal structure of which was recently
solved (Green et al., 2006). The complex was puriﬁed as previously
described (Green et al., 2006). The purity of the bN–RNA protein
complexwas veriﬁed by resolving it in 10% SDS-PAGE followed by CBB
staining and also by Western blot analyses using anti-N and anti-P
antibodies (data not shown). The bN–RNA complex was then digested
with the chymotrypsin under the same reaction conditions as
described from vRNA. In contrast to vN–RNA, the bN–RNA complex
remained totally resistant to the chymotrypsin digestion (Fig. 7,
lane 7). Further puriﬁcation of bN–RNA through the CsCl equilibrium
density gradient ultracentrifugation (bN–RNACsCl) to remove any
contaminating P protein, also failed to produce ΔN fragment upon
treatment with chymotrypsin (Fig. 7, lane 10). These results strongly
suggest that the quaternary structures of the vN–RNA and the bN–
RNA are signiﬁcantly different.
Discussion
TheNproteinof VSVencapsidates the genomicRNA to formvN–RNA
complex and the genomic RNA inside the vN–RNA remains resistant to
RNAase digestion (Banerjee, 1987; Chanda and Banerjee, 1979). The
vN–RNA complex within the virion also packages L and P proteins that
constitute the vRNP which is trancriptionally active in vitro and in vivo.
There are ∼1200 N-protein monomers that encapsidate the genome
RNA (∼11 kb), thus, approximately 1 Nmonomer covers 9 bases. Due to
the large size and complexity the crystal structure of the vRNP or theFig. 7. Chymotrypsin digestion proﬁle of bacterial N–RNA complex. SDS-PAGE analysis
of the puriﬁed bacterial N–RNA complex (bN–RNA) from bacteria and CsCl equilibrium
density gradient puriﬁed bacterial N–RNA complex (bN–RNACsCl) with respect to vN–
RNA complex when digested with and without chymotrypsin at 4.25:1 (w:w) ratio.vN–RNA complexes remained unsolved. Recently, however, the
recombinant N protein expressed in E. coli was found to contain 10
molecules of VSV N protein bound to 90 nucleotides of bacterial RNA
which was subsequently crystallized and its structure solved (Green
et al., 2000; Green et al., 2006). The crystal structure clearly showed that
the N molecules in the complex have a bilobed structure with the
bacterial RNA tightly bound in the cavity at the interface between theN-
and C-terminal lobes. The RNA within the complex was resistant to
nuclease. The RNA binding cavity consisted of side chains of Arg143,
Arg146 and Lys155 fromN-terminal lobe and side chains of Lys286, Arg317
and Arg408 from C-terminal lobe seem to be involved in the binding of
the phosphate groups of the RNA (Green et al., 2006). Each monomer
has an extended N-terminal arm and a C-terminal extended loop. The
network of contacts among the monomers possibly brings the orderly
assembly of theNprotein on the nascent RNAduring replication. Recent
structural analyses of recombinant N–RNA complexes of several viruses
belonging to the mononegavirales order revealed similar bilobed, ring-
like structures (Albertini et al., 2006; Luo et al, 2007; Green et al., 2006;
Green and Luo, 2006;MacLellan et al., 2007; Cox et al., 2009; Tawaret al.,
2009). However, the ability of the recombinantN–RNA complexes to act
as template for viral RdRp heterocomplexes cannot be tested due to the
lack of viral RNA in the complexes.
To gain insight into the arrangement of N proteins on full-length
VSV genomic RNA, we characterized the vN–RNA complex biochem-
ically by digesting it with proteases, such as trypsin, pepsin and
chymotrypsin. Our analyses revealed that chymotrypsin, on limited
proteolysis, can produce a 37 kDa (ΔN) fragment from the 47 kDa full-
length N protein present in the vN–RNA complex (Fig. 1), while
trypsin and pepsin could not digest the vN–RNA (data not shown). LC-
MS studies of the N and ΔN proteins, conﬁrmed that the C-terminal 86
amino acids (NC-86) of the N protein were completely digested by the
chymotrypsin (Fig. 2). It is important to note that the proteolytic
cleavage site (Y336) falls in the α helical region, α-12, just prior to
the extended loop region of the previously solved crystal structure of
bN–RNA, which, interestingly, contains a characteristic unstructured
region (Green et al., 2006 and Fig. 2). Thus, it seems that this extended
loop may be the target for the chymotrypsin action (Fig. 2). Further
analysis showed that both vN–RNA and vΔN–RNA banded at the same
position in the CsCl density gradient ultracentrifugation during the
puriﬁcation, suggesting that the overall structural integrity of the
vΔN–RNA was maintained (Fig. 3). However, the vΔN–RNA failed to
produce mRNA transcripts in transcription reaction when reconsti-
tuted with the vL–P complex in vitro (Fig. 3), but micrococcal nuclease
treatment to the 32P labeled vN–RNA and vΔN–RNA conﬁrmed that
the genomic RNA of VSV in 32P–vΔN–RNA complexes was resistant to
the nuclease treatment (Fig. 3). Coupled with the fact that recent
analyses revealed that point mutations in the C-loop region of the N
protein, although resulted in alerted transcription/replication, where-
as it did not affect RNA encapsidation in vivo (Harouaka and Wertz,
2009), it seems that the NC-86, although indispensable for transcrip-
tion, is not directly involved in protecting the genomic RNA from
nuclease digestion. This region possibly remains protruded out of the
vN–RNA complex, and thus, digestible by chymotrypsin; following
proteolysis the residual N molecules are sufﬁcient to protect the
genome RNA. Consistent with this observation, mutation of a single
amino acid (Ser290→Trp), which lies within the ΔN region, leads to
loss of the capability of the bacterially expressed N protein to
encapsidate RNA (Zhang et al., 2008). Moreover, since the C-terminal
5 amino acids of the N protein have been shown to play a critical role
in encapsidation of the leader RNA in vitro (Das et al., 1999) it is, thus,
possible that the extreme C-terminus of the NC-86might be involved in
the initiation of the encapsidation process.
Subsequentbiochemical analyses revealed that thevΔN–RNA,unlike
vN–RNA, failed to interact to the P protein (Fig. 4). Interestingly, trypsin
digestion of rabies virusN–RNAalso removes aC-terminal region,which
results in loss of P binding (Schoehn et al., 2001). Consistent with this
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meric PCTD (amino acids 178–265 of P protein; consists of an antiparallel
β-turn and 5α-helices) of VSV interactswith two adjacentNmonomers
by binding to the C-loop of the N monomers (Green and Luo, 2009;
Ribeiro et al, 2008; also shown in Fig. 2B). The 17 amino acids of two
adjacent N monomers (11 and 6 residues from each monomer) that
contribute to this speciﬁc interaction are present in a contiguous stretch,
between 354 and 386 (Green and Luo, 2009). Therefore, our data
strongly suggest that the ΔN–RNA failed to act as template in
transcription primarily due to its inability to interact to the P protein
indicating that the vN–RNA complex must interact with the P protein
(and the RdRp) through the NC-86 region (Green and Luo, 2009; Ribeiro
et al, 2009). These interactions, which are mostly H bonds and
hydrophobic interactions are, as suggested, transient and a ‘dynamic
make and break’ of these interactions, is necessary to facilitate the
movement of the RdRp to the next N molecule and hence the next 9
nucleotides of the genome RNA (Green and Luo, 2009; Longhi, 2009).
Our further biochemical analyses revealed that excess amount of
P protein interacts with the vN–RNA complex and renders the latter
inaccessible to the chymotrypsin action (Fig. 5). It appears that the
small vN–RNA binding domain of P protein (Green and Luo, 2009)
is sufﬁcient to protect the complex from chymotrypsin digestion.
Alternatively, the P protein, due to its chaperone action (Chen et al.,
2007; Davis et al., 1986; Masters and Banerjee, 1988a; Masters and
Banerjee, 1988b, Majumder et al., 2001; Majumdar et al., 2004),
might possess intrinsic capability to alter the conformation of the N
protein evenwhen the N protein is present in vN–RNA complex. These
observations are consistent with the fact that the interaction between
N and P proteins causes structural changes in both the proteins and
the signiﬁcant change occurs in the C-loop of the N monomers, where
the P protein interacts to the N protein (Green and Luo, 2009). This
contention was further borne out by our ﬁndings that the structure of
nucleocapsid isolated from the infected cells (iRNP) which contain
excess of intracellular L and P proteins was similarly resistant to
chymotrypsin action (Fig. 6). In contrast, the vRNP which contains a
limited quantity of the P protein release the ΔN protein upon chy-
motrypsin digestion. Interestingly, the iN–RNA that was puriﬁed from
the iRNP, when digested with chymotrypsin, produced the same ΔN
fragment as that of vN–RNA, suggesting that core N–RNA structures of
both complexes are similar (Fig. 6).
Finally, our observation that recombinant bN–RNAwas resistant to
such proteolytic digestion strongly suggests that the quaternary
structure of the complex is different from both vN–RNA and iN–RNA
complexes. It is possible that despite containing the unstructured C-
terminal loop the structure of smaller 10 subunit ring of bN–RNA
complex, due to the close contacts between the N and C-lobes, is
relatively more compact and hence is resistant to proteolytic diges-
tion. Further studies, along these lines may shed light on the detailed
structural aspect of the N–RNA complex.
Material and methods
Cells and viruses
BHK-21 and HeLa cells were maintained in Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum
(FBS). VSVINDMudd–Summers strainwas propagated in BHK-21mono-
layer cells and puriﬁed as described previously (Barik and Banerjee,
1991). Recombinant vaccinia virus (vTF7-3) carrying the bacteriophage
T7 RNA polymerase gene was propagated in HeLa cells.
Puriﬁcation of viral L–P and N–RNA complexes
Puriﬁed viruses were then subjected to further puriﬁcation steps
for the isolation of puriﬁed vRNP, vL–P and vN–RNA complexes as
described earlier (Ogino and Banerjee, 2007).Chymotrypsin treatment of N–RNA complex and puriﬁcation of ΔN–RNA
complex
ThevN–RNA templatewas treatedwith chymotrypsinA (Boehringer
Mannheim) at ratios of 4.25:1, 8.5:1 and 17:1 (w/w) (vN–RNA:
chymotrypsin) in the buffer containing 10 mM Tris–HCl, pH 8.0 at
37 °C for 20 min. Reactionswere stopped by adding Laemmli buffer and
analyzed immediately by SDS-PAGE. A timekineticswas also performed
with the ratio of 4.25:1 (w/w) (vN–RNA:chymotrypsin) in 10 mMTris–
HCl, pH8.0 at37 °C from0 to20 minatdifferent time intervals. 100 µgof
vN–RNA templatewasdigestedwith chymotrypsin at a ratio of 4.25:1 to
generate vΔN–RNA complex and then was diluted in 4 ml of TE buffer
containing 0.1% (w/v) Triton X-100 and CsCl to give an initial density of
1.29 g/cc, and centrifuged to equilibrium in a Sorvall TH-660 rotor at
120,000×g for 16 h at 20 °C. The fractions containing the vΔN–RNA
were diluted eightfold with the high salt buffer, HSB (1600 mM NaCl,
40 mM Tris–HCl [pH 8.0], and 2 mM DTT) and then centrifuged at
120,000×g for 1 h in Sorvall TH-660 rotor. The resulting pellet of the
vΔN–RNA was resuspended in TE buffer containing 10% glycerol and
was dialyzed against the same buffer and then concentrated using
Amicon Ultra-15 centrifugal ﬁlter device (Millipore) and stored at
−80 °C freezer.
Mass spectrometric analysis
The puriﬁed vN–RNA and vΔN–RNA protein bands were cut out
from the gel, divided into smaller pieces, destained and washed with
water and dehydrated in acetonitrile. The protein bands were then
alkylated with iodoacetamide and digested in-gel by adding 5 µl of
20 ng/µl trypsin in 50 mM (NH4)2CO3 and incubated overnight at
room temperature. The resulting peptides were extracted from the
polyacrylamide in two aliquots of 30 µl 50% acetonitrile with 5%
formic acid. These extracts were combined and evaporated to b10 µl
in a speedvac, resuspended in 30 µl of 1% acetic acid and analyzed by
Liquid Chromatography Mass Spectrometry (LC-MS) using a Finnigan
LCQ ion trap mass spectrometer system. A detailed LC-tandem MS
and the CID spectra generated multiple fragments of N protein
sequence (data not shown). These analyses were carried out in the
mass spectrometry core facility of Lerner Research Institute, Cleveland
Clinic.
In vitro transcription reaction
In vitro reconstituted transcription reaction was performed with the
vN–RNA or vΔN–RNA complex and vL–P complex as described earlier
(Ogino and Banerjee, 2007). The synthesized mRNAs were resolved in
5% PAGE containing 7 M urea visualized by autoradiography.
Micrococcal nuclease treatment of 32P labeled viral N–RNA and ΔN–RNA
complexes
For labeling the VSV genome, BHK-21monolayer cells were grown
in conﬂuent manner and infected with VSV at 10 pfu/cell in the
presence of 70 μCi/ml of 32P-orthophosphorus (Perkin-Elmer) and
labeled for 24 h following the previous protocol (Chanda and Banerjee,
1979). 32P-labeled virus was recovered and subsequently 32P-labeled
virion nucleocapsid (32P–vN–RNA) was puriﬁed as described above.
100 µg of 32P–vN–RNA template was digested with chymotrypsin A
at a ratio of 4.25:1 (w/w) (32P–vN–RNA:chymotrypsin) in the buffer
containing 10 mM Tris–HCl, pH 8.0 at 37 °C for 20 min and then was
diluted in 4 ml of TE buffer containing 0.1% (w/v) Triton X-100 and
CsCl to develop an initial density of 1.29 g/cc, and centrifuged to
equilibrium in a Sorvall TH-660 rotor at 120,000×g for 16 h at 20 °C.
The fractions containing the 32P–vΔN–RNA were then puriﬁed fol-
lowing the above mentioned protocol. 3 μg of 32P–vN–RNA or 32P–
vΔN–RNA was digested in separate reaction mixtures containing 0,
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50 mM Tris–HCl, pH 8.0, and 4 mM CaCl2 and digested at 30 °C for 1 h.
The reactions were stopped with 10 mM ethylene glycol tetraacetic
acid (EGTA) to inactivate the nuclease and SDS was added to a ﬁnal
concentration of 0.5%. The micrococcal nuclease digested 32P labeled
RNA sampleswere analyzed by 5% PAGE containing 7 Murea, followed
by auto radiography.
In vitro complex formation between viral N–RNA/ΔN–RNA and P protein
HeLa cells were infected with recombinant vaccinia virus (vTF7-3)
expressing T7 RNA polymerase and at 2 h of post-infection cells were
transfected with 1 μg of plasmid expressing Myc-P (Chen et al., 2006)
using lipofectin (Invitrogen) using manufacturer's protocol. At 20 h
post-transfection cells were lysed and 216 μg of either Myc-P or mock
cell lysates was incubated with either 5 μg of vN–RNA or vΔN–RNA at
30 °C for 1 h in a buffer containing 50 mM Tris (pH 8.0), 100 mMNaCl,
5 mM MgCl2 and 1 mM DTT. These reaction mixtures were then
diluted 40 times in the same buffer and centrifuged at 120,000×g for
1 h using a Sorvall TH-660 rotor. The protein complexes pelleted at
the bottom of the tube were suspended in SDS-PAGE loading buffer,
boiled and resolved in 10% SDS-PAGE. The resolved proteins were
analyzed byWestern blot using anti-N and anti-Myc rabbit polyclonal
antibodies (Chen et al., 2007).
Puriﬁcation of the bacterially expressed VSV P protein
The plasmid pET-3a-VSVIND-PHis containing P gene of Indiana
serotype with histidine tag (Chen et al., 1997) was transformed into
E. coli BL21 (DE3) and the his-tagged P protein was puriﬁed as
described previously with slight modiﬁcations in the protocol (Barik
and Banerjee, 1991). In brief, bacterial cells, induced with IPTG, were
harvested by centrifugation and suspended in 15 ml of buffer P-1
(50 mM Tris–HCl [pH 7.5], 10% glycerol, 1 mM DTT, and 0.1 mM
EDTA) and protease-inhibitor cocktail (Roche Applied Sciences). Then
1.5 ml of 50 mM EDTA, 10% Triton X-100, and 2.5 mg/ml of lysozyme
were added and the suspension was incubated in ice for 45 min with
occasional mixing. The lysed cell mass was brieﬂy sonicated to break
DNA and centrifuged at 100,000×g for 45 min in Sorvall TH-641 rotor.
The pellet containing nearly all of the expressed His-P protein was
dissolved in 20 ml of buffer P-2 containing 100 mM NaH2PO4, and
10 mM Tris–HCl [pH 8.0] containing 6 M guanidine hydrochloride
with the aid of a homogenizer in the cold and incubated in ice for
another 20 min. This soluble His-P protein solution was loaded on a
pre equilibrated Ni-NTA column. The bound protein in column matrix
was washed with the washing buffer (100 mMNaH2PO4, 10 mM Tris–
HCl [pH 6.3], and 8 M urea) and ﬁnally His-P protein was eluted
with elution buffer (100 mM NaH2PO4, 10 mM Tris–HCl [pH 4.5],
and 8 M urea). The eluted protein sample was dialyzed against P-3
buffer (50 mM Tris–HCl [pH 8.0], 100 mM NaCl, 1 mM DTT, and 10%
glycerol) with three changes and then concentrated using Amicon
Ultra-15 centrifugal ﬁlter device (Millipore). Protein concentration
was determined using Bradford reagent (BioRad) and the purity of
the P protein was checked by SDS-PAGE (SDS-polyacrylamide gel
electrophoresis) and Western blot analyses.
Puriﬁcation of bacterially expressed mumps virus P protein
For the puriﬁcation of mumps virus (MuV; strain 88-1961) P
protein a single vector (NP-P-pET28b) co-expressing the MuV NP
protein and N-terminally His-tagged P protein was used (Cox et al.,
2009). The plasmid was transformed into E. coli strain BL21 (DE3) and
the bacterial cells were grown at 37 °C in LB broth in the presence of
kanamycin (30 mg/ml). After reaching an optical density of 0.6 at
600 nm (A600), protein expression was induced with 1 mM IPTG at
29 °C for 6 h. The cells were then collected by centrifugation andresuspended in a buffer containing 20 mMTris (pH 7.9), 500 mMNaCl
and 5 mM imidazole. Cells were then sonicated and centrifuged for
1 h at 14,000 rpm. Soluble fractions were then collected and passed
through a Ni-afﬁnity column (HiTrap Chelating HP, GE Healthcare) in
accordance with the manufacturer's protocol. The NP and P proteins
were eluted from the Ni-afﬁnity column as a complex and were
further separated by ion exchange chromatography (Hitrap Q HP, GE
Healthcare). The NP protein was found to bind to the Hitrap Q HP
columnwhile the His-P protein was detected in the ﬂow through. The
ﬂow through was then passed through the Ni-afﬁnity column and
elution fractions containing the His-P protein were further puriﬁed on
a Sephacryl S-300 column (GE Healthcare) using a buffer containing
50 mM Tris (pH 7.5), and 500 mM NaCl. Fractions containing the
recombinant P protein were then concentrated using a Ni-afﬁnity
column (HiTrap Chelating HP, GE Healthcare) and eluted into a buffer
containing 50 mMTris (pH 7.5), 500 mMNaCl, and 500 mM imidazole
and then dialyzed against a buffer containing 50 mM Tris (pH 8.0),
100 mMNaCl and 1 mMDTT containing 10% (v/v) glycerol for further
use.
In vitro protease protection assay of vN–RNA complexed with VSV
P protein
The vN–RNA and the VSV His-P protein (expressed and puriﬁed
from E. coli) were incubated in 10 mM Tris–HCl, pH 8.0 buffer for 1 h
at 30 °C water bath to form complexes. The molar ratios between vN–
RNA and P were varied from 5:0, 5:1, 5:2.5, 5:5, 5:7.5 to 5:10. These
reaction mixtures were then subjected to chymotrypsin treatment
at 4.25:1 (w/w) (vN–RNA:chymotrypsin) ratio at 37 °C for 20 min
and the digestion proﬁle was studied by 10% SDS-PAGE (acrylamide:
bis-acrylamide=30:0.4) analysis.
Puriﬁcation of infected cell RNP and N–RNA from BHK-21 cells
Infected cell VSV RNP and N–RNA were puriﬁed following the
previously described method with some modiﬁcations (Toneguzzo
and Ghosh, 1976). In brief, conﬂuent monolayer of BHK-21 cells were
infected with VSVIND Mudd–Summers strain at 10 pfu/cell and
incubated at 37 °C for 6 h. After 6 h post-infection, cells were washed
twice with 1× PBS and collected by a cell scrapper in 20 ml 1× PBS.
VSV infected cells were recovered by centrifugation at 800×g for
10 min at 4 °C. Cell pellets were suspended in dounce buffer (10 mM
Tris–HCl, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, and 10%
glycerol) at a ratio of 10 ml/60 plates (150 mm) and were allowed to
swell on ice for 30 min. Cells were disrupted by 60 strokes in a dounce
homogenizer on ice in the presence of protease-inhibitor cocktail
(Roche applied Sciences). Finally, KCl was added to this disrupted cell
suspension to get a ﬁnal concentration of 150 mM. Cellular debris
was removed by centrifugation at 10,000×g for 20 min at 4 °C. The
10,000×g supernatant fraction was collected and again centrifuged at
120,000×g in Beckman SW40 Ti rotor for 2 h at 4 °C. A milky white
pellet of infected cell ribonucleoprotein complex (iRNP) was pelleted
at the bottom of the tube. This iRNP was further solubilized in 20 mM
Tris–HCl, pH 8.0, 1 mMEDTA, and 10% glycerol. This iRNP solutionwas
then layered on 30% glycerol layer in 10 mM Tris–HCl, pH 7.5, 10 mM
KCl, and 1.5 mM MgCl2 buffer having 100% glycerol as a cushion
underneath and centrifuged at 155,000×g for 4 h at 4 °C in Sorvall TH-
641 rotor. The iRNP was collected above the glycerol cushion and
diluted with 1× TE buffer to make the glycerol concentration in
between 10% and 16%. This step was again repeated and ﬁnally the
iRNP was collected in TE buffer. The iRNP was treated with equal
volume of 2× HSB and incubated on ice for at least 1 h with occasional
inverting to dissociate the infected cell polymerase (iL-P) complex
from the infected cell nucleocapsid (iN–RNA) complex. Then the iN–
RNA complex was further puriﬁed by CsCl equilibrium density
gradient ultracentrifugation as discussed above.
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The puriﬁed bacterial N–RNA complex (bN–RNA) (Green et al.,
2006) was either used directly for chymotrypsin digestion or puriﬁed
through CsCl equilibrium density gradient centrifugation prior to
chymotrypsin treatment. After CsCl density gradient ultracentrifuga-
tion for 16 h, fractions were collected and each fraction was analyzed
by 10% SDS-PAGE followed by CBB stain. The layers containing the
bN–RNA were then collected, diluted eightfold with the HSB and
centrifuged again at 120,000×g for 1 h at 4 °C in Sorvall TH-660 rotor.
The obtained pellet (bN–RNACsCl) was suspended in TE buffer con-
taining 10% glycerol, was dialyzed against the same buffer and con-
centrated using Amicon Ultra-15 centrifugal ﬁlter device (Millipore)
and was stored at−80 °C freezer for future use. The puriﬁed vN–RNA,
bN–RNA and bN–RNACsCl were subjected to chymotrypsin digestion
following the protocol described above and the digestion proﬁle
was studied in 10% SDS-PAGE (acrylamide:bis-acrylamide=30:0.4)
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